Ringers (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Ringers drug offered from Baxter Healthcare Corporation. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: Sodium Chloride, Calcium Chloride, Potassium Chloride
SUBSTANCE NAME: SODIUM CHLORIDE; CALCIUM CHLORIDE; POTASSIUM CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1971-03-22
END MARKETING DATE: 0000-00-00


Ringers HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRingers from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 8.6; .33; .3(g/1000mL; g/1000mL; g/1000mL)
START MARKETING DATE: 1971-03-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-0105_7c2d5806-0dd7-4d59-b4c3-87b052567d9d
PRODUCT NDC: 0338-0105
APPLICATION NUMBER: NDA016693

Other SODIUM CHLORIDE; CALCIUM CHLORIDE; POTASSIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Ringers
Baxter Healthcare CorporationRingers